Carlson Financial’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
CIS
MWM
GAM
Carlson Financial's SBIO Position: Q2 2026 in Review
Carlson Financial reduced its ALPS Medical Breakthroughs ETF (SBIO) stake by 0.04% in Q2 2026, selling an estimated $164 and leaving 7,448 shares worth $482K. The position accounts for 0.25% of the portfolio, ranked #89.
Carlson Financial first reported a position in SBIO in Q4 2025 and has held it in 3 quarters since. 65 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.
- Carlson Financial held 7,448 shares of ALPS Medical Breakthroughs ETF worth $482K as of Q2 2026.
- Carlson Financial sold 3 ALPS Medical Breakthroughs ETF shares in Q2 2026, an estimated $164.
- ALPS Medical Breakthroughs ETF made up 0.25% of Carlson Financial's portfolio in Q2 2026, its #89 holding.
- Carlson Financial first reported a position in ALPS Medical Breakthroughs ETF in Q4 2025 and has held it in 3 quarters since.
- 65 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.
Based on Carlson Financial's 13F filing for Q2 2026, filed 24 Aug 2026.